A 38-year-old woman presents to the ENT clinic with a 2-year history of a painless, slowly enlarging swelling in the left submandibular region. On examination, the mass is mobile, non-tender, and measures 3 cm. Intraoral examination shows a smooth bulge on the floor of mouth. MRI reveals a well-defined, heterogeneous mass with areas of high signal intensity on T2-weighted images. FNAC is inconclusive. What is the most appropriate next step in management?

Explanation

## Management Algorithm for Salivary Gland Tumors ### Clinical Context This patient has a **submandibular gland mass** with: - 2-year indolent history (slow growth) - Mobile, well-defined mass on imaging - MRI showing heterogeneous signal with T2 hyperintensity - **Inconclusive FNAC** **High-Yield:** For salivary gland tumors, **FNAC has limited sensitivity and specificity**. When FNAC is inconclusive or non-diagnostic, the next step is NOT repeat sampling but **definitive surgical management**. ### Diagnostic Approach for Salivary Gland Masses ```mermaid flowchart TD A[Salivary gland mass]:::outcome --> B{Clinical features}:::decision B -->|Mobile, well-defined| C[Likely benign]:::action B -->|Fixed, skin involvement| D[Likely malignant]:::urgent C --> E[FNAC/Core needle biopsy]:::action D --> E E --> F{Diagnostic?}:::decision F -->|Positive for malignancy| G[Imaging + surgical planning]:::action F -->|Benign features| H[Surgical excision]:::action F -->|Inconclusive/Non-diagnostic| I[Proceed to surgery]:::action G --> J[Radical surgery ± adjuvant]:::action H --> K[Gland-preserving or gland excision]:::action I --> K K --> L[Histopathology]:::outcome ``` ### Why Submandibular Gland Excision? **Key Point:** The submandibular gland is a **minor salivary gland with high malignancy risk** (~50% of submandibular tumors are malignant, vs. ~20% of parotid tumors). **Clinical Pearl:** In the submandibular region, when a mass is: 1. Intraoral (floor of mouth bulge) 2. Well-defined on imaging 3. Arising from the gland itself 4. Non-diagnostic on FNAC → **Surgical excision with histopathology is the gold standard**. ### Why NOT the Other Options? | Option | Why Incorrect | |--------|---------------| | **Repeat FNAC** | FNAC has ~65% sensitivity for salivary tumors; repeating an inconclusive test wastes time. Definitive diagnosis requires histology. | | **Core needle biopsy** | While higher sensitivity than FNAC, core biopsy risks tumor seeding and is not standard for potentially resectable gland tumors. | | **Excision biopsy with frozen section** | Excision biopsy is appropriate, but the **entire submandibular gland should be excised** (not just the mass) because: (1) malignancy risk is high, (2) intraoperative frozen section may miss low-grade malignancies, (3) gland excision is the definitive treatment. | **Warning:** Do NOT perform incisional biopsy or partial mass excision of salivary gland tumors — risk of tumor spillage, seeding, and inadequate treatment. ### Surgical Principles for Submandibular Gland Tumors **Mnemonic: SAFE** — **S**urgical excision, **A**void spillage, **F**ascial plane respect, **E**xplore nerve integrity 1. **Submandibular gland excision** is standard for any tumor of the gland 2. Preserve lingual and hypoglossal nerves if possible 3. Histopathology determines grade and need for adjuvant therapy 4. If malignancy confirmed → consider neck dissection and/or adjuvant radiotherapy **High-Yield:** Submandibular gland excision is both **diagnostic and therapeutic** — it provides definitive histology while removing the tumor in one procedure.